Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass
- 1 March 2006
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 154 (3) , 409-417
- https://doi.org/10.1530/eje.1.02097
Abstract
Objective: Pheochromocytomas are neoplasms generally characterized by the autonomous production of catecholamines. This study compared various biochemical parameters for the diagnosis of adrenal pheochromocytoma in patients with adrenal mass. Design: One hundred and fifty subjects were studied, including 24 histologically proven pheochromocytomas, 17 aldosterone-secreting and 21 cortisol-secreting adrenal adenomas and 30 nonfunctioning adrenal masses, 16 patients with essential hypertension and 42 healthy normotensive volunteers. Spontaneous blood samples and 24-h urine samples were collected prospectively. Methods: Plasma and urinary epinephrine and norepinephrine levels were measured by high performance liquid chromatography, whereas plasma and urinary metanephrine and normetanephrine levels were determined by radioimmunoassay (RIA). Putative ratio thresholds were calculated by receiver operating characteristic (ROC) analysis to balance between sensitivity and specificity. Results: Plasma normetanephrine was found to be the best single parameter with the highest sensitivity (91.7%) and specificity (95.6%) using a threshold of 126 pg/ml. In combination, plasma normetanephrine and metanephrine had a higher sensitivity of 95.8% with lower specificity (79.4%). All other combinations of plasma and/or urinary parameters demonstrated a lower accuracy. Conclusion: Plasma metanephrines measured by RIA are reliable screening parameters for the diagnosis of pheochromocytoma.Keywords
This publication has 15 references indexed in Scilit:
- PhaeochromocytomaThe Lancet, 2005
- Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test ResultsJournal of Clinical Endocrinology & Metabolism, 2003
- Biochemical Diagnosis of Pheochromocytoma—Is it Time to Switch to Plasma-Free Metanephrines?Journal of Clinical Endocrinology & Metabolism, 2003
- A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and CatecholaminesJournal of Clinical Endocrinology & Metabolism, 2003
- Biochemical Diagnosis of PheochromocytomaJAMA, 2002
- Plasma metanephrines: a novel and cost-effective test for pheochromocytoma.Brazilian Journal of Medical and Biological Research, 2000
- Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel–Lindau Disease and Multiple Endocrine Neoplasia Type 2New England Journal of Medicine, 1999
- Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within TumorsJournal of Clinical Endocrinology & Metabolism, 1998
- Malignant pheochromocytomaExperimental and Clinical Endocrinology & Diabetes, 1998
- Plasma Metanephrines in the Diagnosis of PheochromocytomaAnnals of Internal Medicine, 1995